Medarex Medical Monitor
Medarex
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Medarex Medical Monitor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00730652 · Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell LymphomaBristol-Myers Squibb · withdrawn · Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma. · study director
- Ph2NCT00284804 · A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's DiseaseBristol-Myers Squibb · completed · Hodgkin's Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.